Post by Joseph Perekupka

Healthcare Executive | Scaling MedTech & Digital Therapeutics Companies | Commercial Strategy • Market Access • Executive Leadership

Today, on the cover of Nature Medicine, a 3.5-year first-in-human clinical study conducted by Chad Bouton, PhD, and his team demonstrated 'double neural bypass' technology to restore movement and sensation in tetraplegia and the brain's & spinal cord's own capacity to heal. The takeaway: the future of neurotechnology isn't just connecting brain to machine—it's building Brain-Body Interfaces that adapt over time and drive lasting recovery. This isn't just another brain-computer interface milestone. It's a new generation of neurotherapeutic platforms restoring movement, sensation, and the brain's own capacity to heal—with real implications for spinal cord injury, stroke, and beyond. https://lnkd.in/gMJraKTb

Post content